Search

everythinglearnresearchcommunity

for

Search:↓

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

PCOS has many symptoms, with high androgen levels being the most common.

A very low-calorie ketogenic diet led to weight loss and improved metabolic and hormonal health in obese men, with better sperm motility.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Gut microbes significantly affect brain steroid levels.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Piptadeniastrum africanum and Cordia plathytyrsa can increase testosterone without major metabolic changes, but may affect triglycerides and creatinine.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Method measures finasteride in plasma, suitable for pharmacokinetic studies.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.